This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Hiroshima Institute of Life Sciences. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Daiki Miki: Innovator in Hepatitis B Research
Introduction
Daiki Miki is a prominent inventor based in Hiroshima, Japan. He has made significant contributions to the field of medical research, particularly in the fight against viral infections. His work focuses on developing innovative solutions to combat hepatitis B virus (HBV) infections.
Latest Patents
Daiki Miki holds a patent for a "Human NTCP-Binding Antibody Capable of Inhibiting Infection of Hepatitis B Virus (HBV) to Human Hepatocytes." This groundbreaking invention aims to provide a new therapeutic approach to prevent HBV from infecting liver cells, which is crucial for improving treatment options for patients.
Career Highlights
Miki is affiliated with the Hiroshima Institute of Life Sciences, where he conducts his research. His dedication to advancing medical science has led to the development of this important patent, showcasing his commitment to addressing public health challenges.
Collaborations
Daiki Miki collaborates with esteemed colleagues, including Michishige Harada and Takehisa Matsumoto. Their combined expertise enhances the research efforts at the Hiroshima Institute of Life Sciences, fostering an environment of innovation and discovery.
Conclusion
Daiki Miki's contributions to hepatitis B research exemplify the impact of innovative thinking in the medical field. His patent represents a significant step forward in the fight against viral infections, highlighting the importance of continued research and collaboration in advancing healthcare solutions.